RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS
https://doi.org/10.21518/2079-701X-2017-4-7-10
Abstract
The review focuses on respiratory syncytial virus infection (RSVI) and, based on the literature and authors' own observations, highlights epidemiological aspects and risk factors for RSVI (including severe forms of the infection), the specific clinical manifestations, challenges of laboratory diagnostics, and the benefits of various methods and their relevance in clinical practice. The available types of RSVI therapies are discussed based on meta-analyses of the data. The authors emphasize the importance of palivizumab in the specific passive prevention of respiratory syncytial virus infection in children from risk groups.
About the Authors
K. V. YEVDOKIMOV
St. Petersburg Scientific-Research Institute of Children's Infections of the Federal Medical and Biological Agency
Russian Federation
Russian Federation
V. B. ROVNIY
North-Western State Medical University named after I.I. Mechnikov, MoH RF
Russian Federation
Russian Federation
I. V. BABACHENKO
St. Petersburg Scientific-Research Institute of Children's Infections of the Federal Medical and Biological Agency
St. Petersburg State Pediatric Medical University, MoH RF
Russian Federation
Russian Federation
E. V. SHARIPOVA
St. Petersburg Scientific-Research Institute of Children's Infections of the Federal Medical and Biological Agency
Russian Federation
Russian Federation
References
1. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis, 2012, 54: 1427-1436.
2. Mejias A, Ramilo O. Defining the burden of respiratory syncytial virus infection. J Pediatr (Rio J), 2013, 89: 517-9.
3. Ровный В.Б. Клинико-эпидемиологическая характеристика респираторно- синцитиальной вирусной инфекции у больных с поражением нижних отделов респираторного тракта: автореф. дис. .. канд. мед. наук. СПб.: СЗГМУ им. И.И. Мечникова, 2014. 16 с.
4. Waris M, White LJ. Seasonality of Respiratory Syncytial Virus Infection. Clin Infect Dis, 2006, 43(4): 541.
5. Ferrero F, Torres F, Abrutzky R, Ossorio MF, Marcos A, Ferrario Cl and Rial MJ. Seasonality of respiratory syncytial virus in Buenos Aires relationship with global climate change. Arch Argent Pediatr 2016, 114(1): 52-55.
6. Нотарио Д., Таточенко В., Учайкин В. и др. Эпидемиология респираторно- синцитиального вируса у детей в возрасте ≤ 2 лет, госпитализированных с инфекцией нижних дыхательных путей в Российской Федерации. Clinical Epidemiology, 2010, 2: 1-7.
7. Ровный В.Б. и др. Клинико-эпидемиологические особенности респираторно- синцитиальной инфекции у детей разного возраста. Журнал инфектологии, 2013, 5(2): 76-81.
8. Lanari M, Prinelli F, Adorni F, Di Santo S, Vandini S, Silvestri M et al. Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort. Italian Journal of Pediatrics, 2015, 41: 40.
9. Eposito S and Lelii M. Vitamin D and respiratory tract infections in childhood. BMC Infectious Diseases, 2015, 15: 487.
10. Maxwell. CS, Carbone ET and Wood RJ. Better newborn vitamin D status lowers RSV- associated bronchiolitis in infants. Nutrition Reviews, 2012, 70: 548-552.
11. Byington CL, Wilkes J, Korgenski K, Sheng X. Respiratory Syncytial Virus-Associated Mortality in Hospitalized Infants and Young Children. Pediatrics, 2015 Jan, 135(1): e24-e31.
12. Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK et al. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J Infect Dis, 2016 Dec 15, 214(12): 1924- 1928.
13. de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC et al. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med, 2016 Nov 1, 194(9): 1104-1115.
14. Liu W, Chen D, Tan W, Xu D, Qiu S, Zeng Z et аl. Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCR. PLoS One, 2016 Oct 20, 11(10): e0165108.
15. Ровный В.Б. и др. Острая респираторно-синцитиальная вирусная инфекция у детей в возрастном аспекте. Детские инфекции, 2013, 12(4): 19-23.
16. Рудакова А.В., Бабаченко И.В., Ровный В.Б., Усков А.Н., Лобзин Ю.В. / Эффективность затрат на профилактику тяжелой респираторно-синцитиальной инфекции паливизумабом у недоношенных детей первого года жизни. Вопросы Современной Педиатрии, 2012, 11(4): 142-147.
17. Barenfanger J, Drake C, Leon N, Mueller T, Troutt T. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J Clin Microbiol, 2000, 38: 2824-8.
18. Popow-Kraupp T and Aberle JH. Diagnosis of Respiratory Syncytial Virus Infection. The Open Microbiology Journal, 2011, 5(Suppl2-M2): 128-134.
19. Canducci F, Debiaggi M, Sampaolo M et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory diseases. J Med Virol, 2008, 80: 716-23.
20. Ровный В.Б. Клинико-эпидемиологическая характеристика респираторно- синцитиальной вирусной инфекции у больных с поражением нижних отделов респираторного тракта: дис. … канд. мед. наук. СПб.: СЗГМУ им. И.И. Мечникова, 2014. 137 с.
21. Drysdale SB, Green CA and Sande CJ. Best practice in the prevention and management of paediatric respiratory syncytial virus infection. Ther Adv Infect Dis, 2016, 3(2): 63-71.
22. Бабаченко И.В., Ибрагимова О.М., Ровный В.Б. Респираторно-синцитиальная вирусная инфекция у детей: клинико-эпидемиологические аспекты, современные возможности лечения и профилактики: медицинское пособие. Пути снижения детской смертности от инфекционных и паразитарных заболеваний: Российский опыт: материалы II междунар. форума. СПб.: Человек и его здоровье, 2012: 59-86.
23. National Institute for Health and Care Excellence (NICE). Bronchiolitis: diagnosis and management of bronchiolitis in children. Clinical Guideline, 2015, 9.
24. Bentley A, Flipovic I, Gooch K, Busch K. A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom. Health Economics Review, 2013, 3: 18.
Review
For citations:
YEVDOKIMOV KV, ROVNIY VB, BABACHENKO IV, SHARIPOVA EV. RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS. Meditsinskiy sovet = Medical Council. 2017;(4):7-10. (In Russ.) https://doi.org/10.21518/2079-701X-2017-4-7-10
Views:
850
Email this article 